Cardiovascular Diseases — Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma
Citation(s)
A Phase I Study of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK 001) in Multiple Myeloma Patients Following Autologous Stem Cell Transplant in the Front-line Setting.